Bronchiectasis Drugs Market, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

Description

The global bronchiectasis drugs market size is estimated to be valued at US$ 334.8 million in 2023 and is expected to reach US$ 660.7 million by 2030, grow at a compound annual growth rate (CAGR) of 10.2 % from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 334.8 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.20%	2030 Value Projection:	US$ 660.7 Mn

Figure 1. Global Bronchiectasis Drugs Market Share (%), By Region, 2023

Bronchiectasis is a condition where damage causes the tubes in your lungs (airways) to widen or develop pouches. It makes it hard to clear mucus out of your lungs and can cause frequent infections. Coughing a lot with pus and mucus is the main symptom of bronchiectasis. Bronchiectasis can't be cured but can be managed with treatment.

Bronchiectasis drugs are essential for managing the symptoms and complications of bronchiectasis, a chronic respiratory condition characterized by widening of the bronchial tubes. These drugs aim to alleviate symptoms like chronic cough, excessive mucus production, and recurrent respiratory infections while slowing down disease progression. Bronchiectasis drugs encompass bronchodilators, mucus-clearing agents, antibiotics, and anti-inflammatory medicine. Their development has opened new possibilities for improved patient outcomes and quality of life. Ongoing research in bronchiectasis explores novel therapeutic approaches and targeted medications, offering hope for more effective treatments and better disease management.

Market Dynamics:

The increasing prevalence of bronchiectasis, advancements in treatment options, and increasing focus on personalized medicine are anticipated to drive growth of the global bronchiectasis drugs market over the forecast period. Moreover, a supportive regulatory environment and increased research and developmental activities by market players is expected to drive market growth over the forecast period.

For instance, in February 2022, Armata Pharmaceuticals, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared Armata's Investigational New Drug (IND) application to initiate a clinical trial of its optimized lead therapeutic candidate, AP-PA02, in a second indication, non-cystic fibrosis bronchiectasis.

Key features of the study:

This report provides in-depth analysis of the global bronchiectasis drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bronchiectasis drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, GlaxoSmithKline, Boehringer Ingelheim, Novartis, AstraZeneca, Sunovion Pharmaceuticals, Chiesi Farmaceutici
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global bronchiectasis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bronchiectasis drugs market

Detailed Segmentation:

Bronchiectasis drugs market, By Drug Class:
- Antibiotics
- Mucolytics
- Bronchodilators
- Anti-inflammatory agents
Bronchiectasis drugs market, By Route of Administration:
- Oral
- Inhalation
- Intravenous
Bronchiectasis drugs market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Bronchiectasis drugs market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- Bayer
- GlaxoSmithKline
- Boehringer Ingelheim
- Novartis
- AstraZeneca
- Sunovion Pharmaceuticals
- Chiesi Farmaceutici

Product Code: CMI6011

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Bronchiectasis Drugs, By Drug Class
- Market Bronchiectasis Drugs, By Route of Administration
- Market Bronchiectasis Drugs, By Distribution Channel
- Market Bronchiectasis Drugs, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Prevalence of Bronchiectasis
Increasing Awareness of the Disease
- Restraints
Limited Awareness and Underdiagnoses
Lack of Specific Treatment Guidelines
- Opportunities
Unmet Medical Needs
Emerging Markets
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Bronchiectasis Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Bronchiectasis Drugs Market , By Drug Class, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Mucolytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Anti-inflammatory agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Bronchiectasis Drugs Market , By Route of Administration, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Bronchiectasis Drugs Market, By Distribution Channel, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Bronchiectasis Drugs Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
China
Japan
India
South Korea
ASEAN
Australia
Rest of Middle East
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country , 2018-2030,(US$ Mn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Bayer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Chiesi Farmaceutici
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us